aod9604 amino acid sequence AOD-9604 5mg Canada — Janoshik Tested Research Peptide 🔥 What is AOD-9604? AOD

Thank you for your understanding and support in helping us keep our clinics running smoothly.

Findings in Beta-3-Adrenergic-Receptor Knockout Mice Another mouse study investigated the relationship between AOD9604 and beta-3-adrenergic-receptor biology

Mechanism studied NNMT catalyses the methylation of nicotinamide

This suggests that AOD 9604 may potentially augment the anti-cancer potency of doxorubicin while possibly minimizing unintended actions associated with non-target tissue exposure

5Amino-1MQ 5-Amino-1MQ is a small-molecule compound targeting the NNMT pathway, and its currently being studied for its role in cellular metabolism, energy regulation, and adipocyte-related biochemical models

Fat Loss & Metabolic Enhancement (Weight Management) Dosage: 300500 mcg per day, injected subcutaneously (SC) Cycle: Continuous use for 812 weeks, followed by a 4-week break Administration: Best injected in the morning or pre-workout on an empty stomach Stacking: Can be combined with CJC-1295 (w/o DAC), Ipamorelin, or Tesamorelin for enhanced GH-related fat loss Expected Benefits: Increased fat burning, improved energy expenditure, enhanced metabolic function 2